We are live on ! Find out more
SM

SG3 Management Portfolio holdings

AUM $6.45K
1-Year Est. Return 61.81%
This Fund
S&P 500
This Quarter Est. Return
+12.91%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
–
AUM
$4.92B
AUM Growth
+$1.62B
Cap. Flow
+$1.41B
Cap. Flow %
28.67%
Top 10 Hldgs %
36.75%
Holding
1,419
New
468
Increased
176
Reduced
163
Closed
410

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$208M
2
AMZN icon
Amazon
AMZN
+$165M
3
AMD icon
Advanced Micro Devices
AMD
+$86.9M
4
XYZ
Block Inc
XYZ
+$33.2M
5
ROKU icon
Roku
ROKU
+$27M

Top Sells

Rank Stock Value
1
XLRN
Acceleron Pharma
XLRN
+$10.3M
2
MRNA icon
Moderna
MRNA
+$9.79M
3
JD icon
JD.com
JD
+$6.14M
4
AZN icon
AstraZeneca
AZN
+$5.27M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$4.32M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 8.5%
2 Technology 4.33%
3 Communication Services 2.49%
4 Healthcare 1.87%
5 Financials 0.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DRNA
1401
PUT
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
– –
-30,000
Closed -$605K
HRC
1402
CALL
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
– –
-12,300
Closed -$1.84M
HRC
1403
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
– –
-4,000
Closed -$600K
PPD
1404
CALL
DELISTED
PPD, Inc. Common Stock
PPD
– –
-7,000
Closed -$328K
PPD
1405
PUT
DELISTED
PPD, Inc. Common Stock
PPD
– –
-11,000
Closed -$515K
MDP
1406
CALL
DELISTED
Meredith Corporation
MDP
– –
-5,000
Closed -$279K
MDP
1407
PUT
DELISTED
Meredith Corporation
MDP
– –
-19,000
Closed -$1.06M
INOV
1408
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
– –
-105,000
Closed -$4.23M
INOV
1409
PUT
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
– –
-164,000
Closed -$6.61M
XLRN
1410
CALL
DELISTED
Acceleron Pharma
XLRN
– –
-246,100
Closed -$42.4M
XLRN
1411
DELISTED
Acceleron Pharma
XLRN
– –
-60,000
Closed -$10.3M
XLRN
1412
PUT
DELISTED
Acceleron Pharma
XLRN
– –
-95,000
Closed -$16.4M
TRIL
1413
CALL
DELISTED
Trillium Therapeutics Inc.
TRIL
– –
-20,000
Closed -$351K
CLDR
1414
CALL
DELISTED
Cloudera, Inc.
CLDR
– –
-9,900
Closed -$158K
GRUB
1415
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
– –
-13,420
Closed -$179K
COWN
1416
CALL
DELISTED
Cowen Inc. Class A Common Stock
COWN
– –
-1,100
Closed -$38K
COWN
1417
DELISTED
Cowen Inc. Class A Common Stock
COWN
– –
-4,000
Closed -$137K
BDSI
1418
DELISTED
BioDelivery Sciences International, Inc.
BDSI
– –
-10,000
Closed -$33.7K
BDSI
1419
PUT
DELISTED
BioDelivery Sciences International, Inc.
BDSI
– –
-20,300
Closed -$73K
53 54 55 56
57

Similar funds

EAM
Emso Asset Management London, United Kingdom $255K AUM 6.95% 1-Year Est. Return
CAM
Chatham Asset Management Chatham, New Jersey $376K AUM
CCM
Compton Capital Management Providence, Rhode Island $4.32M AUM 27.38% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
MAM
Moelis Asset Management New York $5.32M AUM
BGCI
Bertram Growth Capital III Foster City, California $6.05M AUM 39.41% 1-Year Est. Return
TPL
Tao Pro LLC San Francisco, California $13.8M AUM 74.14% 1-Year Est. Return
RC
Resonate Capital San Francisco, California $15.4M AUM 24.26% 1-Year Est. Return

SG3 Management's Q4 2021 Portfolio in Review

As of Q4 2021, SG3 Management held 1,419 positions worth $4.92B, up 49% from $3.3B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

SG3 Management deployed $1.41B of net new capital in Q4 2021, opening 468 new positions and adding to 176 existing holdings. Its largest new stake was Tesla: 619,500 shares worth $218M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 8.5% of assets, up from 0.74% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Moderna, an estimated $9.79M trimmed.

  • SG3 Management's largest Q4 2021 buy was Tesla: 619,500 shares worth $218M.
  • SG3 Management added most to Amazon in Q4 2021, an estimated $165M increase.
  • SG3 Management's biggest Q4 2021 reduction was Moderna, cutting an estimated $9.79M.
  • SG3 Management fully exited Acceleron Pharma in Q4 2021, selling an estimated $10.3M.
  • SG3 Management's ten largest holdings make up 37% of its $4.92B portfolio in Q4 2021.
  • SG3 Management opened 468 new positions and closed 410 in Q4 2021.
  • SG3 Management's portfolio value rose 49% quarter-over-quarter to $4.92B.

Based on SG3 Management's 13F filing for Q4 2021, filed 15 Feb 2022.